Reduced resistance in the context of cancer refers to the decreased ability of cancer cells to withstand the effects of therapeutic agents such as chemotherapy, radiation, and immunotherapy. This phenomenon can be influenced by various factors including genetic mutations, changes in the tumor microenvironment, and patient-specific characteristics.
